Doctor profile · Federal record
Dr. Charles Wykoff, MD, PHD
Ophthalmology Physician (CMS: Ophthalmology) · Retina Specialist (Ophthalmology) Physician · Bellaire, TX
- NPI 1124237300
- Accepts Medicare
- MIPS 96.4 / 100 · 2023
- 21 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4460 Bissonnet St Ste 200
Bellaire, TX 774013218
(713) 524-3434
fax (713) 524-3220
Credentials & registration
- NPI registered
- May 2007 — 19 yrs on file
- Profile last updated
- January 11, 2022
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State license (1)
- Texas #N9336
- Medicaid
- TX #282988901
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1124237300. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
32,697
Distinct HCPCS
10
Medicare allowed
$7,898,385
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 12,671 | 35 | $36 | |
J0178 |
Injection, aflibercept, 1 mg | 4,844 | 383 | $865 | |
92134 |
Imaging of retina | 3,494 | 1,142 | $40 | |
J2781 |
Injection, pegcetacoplan, intravitreal, 1 mg | 3,135 | 86 | $151 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 2,872 | 101 | $227 | |
67028 |
Injection of drug into eye | 2,609 | 546 | $132 | |
92014 |
Established patient complete exam of visual system | 1,938 | 973 | $124 | |
J3490 |
Unclassified drugs | 419 | 112 | $2,490 | |
Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 207 | 18 | $274 | |
92004 |
New patient complete exam of visual system | 117 | 117 | $148 |
In context: peer comparison
Among 11 peers in Bellaire Ophthalmology Physician, average services per provider: 407. This provider delivers 80× the peer median.Open Payments
Industry payments received
All-time total
$394,856
Transactions
107
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| EyePoint Pharmaceuticals US, INC. | 9 | $115,943.55 | |
| Boehringer Ingelheim International GmbH | 11 | $96,886.96 | |
| Apellis Pharmaceuticals, INC. | 23 | $72,629.25 | |
| Abbvie INC. | 20 | $37,789.22 | |
| Regeneron Pharmaceuticals, INC. | 17 | $17,848.09 | |
| Sanofi US Services INC. | 5 | $13,113.00 | |
| Alcon Vision LLC | 3 | $7,250.00 | |
| F. Hoffmann-la Roche Ag | 6 | $6,780.00 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $4,750.00 | |
| Kowa Research Institute, INC. | 2 | $4,500.00 | |
| BioCryst Pharmaceuticals, INC. | 3 | $4,462.50 | |
| Bayer Healthcare Pharmaceuticals INC. | 1 | $2,520.00 | |
| Bausch & Lomb Americas INC. | 3 | $2,033.64 | |
| Janssen Pharmaceuticals, INC | 1 | $1,815.00 | |
| Alimera Sciences, INC. | 2 | $1,410.29 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
473
Patients
221
Total drug cost
$23,582
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisolone Acetate | Generic | 106 | 66 | $6,889 |
| Latanoprost | Generic | 105 | 37 | $1,829 |
| Ketorolac Tromethamine | Generic | 84 | 40 | $1,850 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 50 | 20 | $1,286 |
| Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) | Brand | 49 | 36 | $575 |
| Prolensa (Bromfenac Sodium) | Brand | 26 | 0 | $9,687 |
| Gatifloxacin | Generic | 24 | 22 | $926 |
| Timolol Maleate | Generic | 16 | 0 | $197 |
| Dorzolamide Hcl | Generic | 13 | 0 | $342 |
Frequently asked questions
What is Dr. Charles Wykoff's medical specialty?
Dr. Charles Wykoff practices Ophthalmology Physician in Bellaire, TX.
Where does Dr. Charles Wykoff practice?
Dr. Charles Wykoff practices at 4460 Bissonnet St Ste 200, Bellaire, TX 774013218. Office phone: 7135243434.
What is Dr. Charles Wykoff's NPI?
Dr. Charles Wykoff's National Provider Identifier (NPI) is 1124237300, issued by NPPES.
Does Dr. Charles Wykoff accept Medicare assignment?
Yes. Dr. Charles Wykoff accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Charles Wykoff commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Injection, aflibercept, 1 mg (HCPCS J0178); Imaging of retina (HCPCS 92134). Source: CMS Medicare Physician & Other Practitioners file.